Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease

CONTEXT: Remission failure following transsphenoidal surgery in Cushing disease (CD) from pituitary corticotroph tumors (CtTs) remains clinically challenging. Histone deacetylase inhibitors (HDACis) are antitumor drugs approved for clinical use, with the potential to affect adrenocorticotropin hormo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Lu, Jie, Chatain, Grégoire P., Bugarini, Alejandro, Wang, Xiang, Maric, Dragan, Walbridge, Stuart, Zhuang, Zhengping, Chittiboina, Prashant
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2017
Assuntos:
Clinical Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546859/
https://ncbi.nlm.nih.gov/pubmed/28505327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2017-00464
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados